Episode 62: Lenacapavir Off Hold - Now What?

NECA in the Know

Jun 23, 2022•11 min•Ep. 62

--:--

Listen in podcast apps:

Apple Podcasts

Spotify

Download

Listen to this episode in Metacast mobile app

Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

This week, we sit down with John Faragon to discuss the clinical hold that's been lifted for lenacapavir - a drug used for HIV treatment. Now that the hold has been lifted, what's next? Tune in to learn all about what lenacapavir is, who it's for, and why HIV providers should be interested in this news.

--

Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=PCS6722)

--
Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes.

--
Check out our free online courses: www.necaaetc.org/rise-courses

--
Download our HIV mobile apps:

Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=US

Apple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691

For the best experience, listen in Metacast app for iOS or Android